Related Experiment Videos
Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor
N J Bishop1, D M Williams, J C Compston
1Department of Paediatrics, Addenbrooke's Hospital, Cambridge.
Insights
Recombinant human granulocyte colony-stimulating factor (G-CSF) treatment improves survival in children with severe congenital neutropenia (SCN). This study shows bone loss in an SCN child, successfully treated with anabolic steroids and bisphosphonates.
Area of Science:
- Pediatric Hematology
- Endocrinology
- Bone Metabolism
Background:
- Severe congenital neutropenia (SCN) is a rare condition affecting neutrophil production.
- Recombinant human granulocyte colony-stimulating factor (G-CSF) significantly improves survival in children with SCN.
- Osteoporosis is a potential complication in SCN patients, possibly linked to the disease or its treatment.
Observation:
- A pediatric patient with SCN presented with severe osteoporosis and vertebral collapse.
- Bone loss was quantitatively assessed using absorptiometric and histomorphometric methods.
- The patient's condition indicated a significant impact of SCN and/or G-CSF therapy on bone health.
Findings:
- Detailed analysis confirmed substantial bone loss in the SCN patient.
- Treatment with anabolic steroids and bisphosphonates led to a positive response.
- Therapeutic intervention demonstrated efficacy in reversing bone loss and improving skeletal integrity.
Implications:
- Anabolic steroids and bisphosphonates may be effective in managing osteoporosis in children with SCN.
- Further research is warranted to elucidate the mechanisms of bone loss in SCN.
- Optimizing bone health management is crucial for improving the long-term quality of life for SCN survivors.
Abstract:
Recombinant human granulocyte colony-stimulating factor (G-CSF) has substantially improved life expectancy for children with severe congenital neutropenia (SCN). Severe osteoporosis, reported in this population, may relate to the disease process, or be a therapeutic side-effect. This report details bone loss, quantitated absorptiometrically and histomorphometrically, in a child with SCN and vertebral collapse, and the positive response to anabolic steroid and bisphosphonate therapy.